JournalsHub
.online
Find My Journal
JB

Jan C. Brase

Novartis (Switzerland) CH

ORCID iD 0000-0002-1325-2528
167
Publications
6,827
Citations
36
H-Index
51
i10-Index
1.09
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

167 total

Combined BRAF, EGFR, and MEK Inhibition in Patients with <i>BRAF</i> V600E-Mutant Colorectal Cancer PDF

Ryan B. Corcoran, Thierry André, Chloé E. Atreya, Jan H.M. Schellens, Takayuki Yoshino et al. - Cancer Discovery, 2018
Cited by 577 OpenAlex

Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2–Positive and Triple-Negative Primary Breast Cancers PDF

Carsten Denkert, Gϋnter von Minckwitz, Jan C. Brase, Bruno V. Sinn, Stephan Gade et al. - Journal of Clinical Oncology, 2014
Cited by 1,021 OpenAlex

Circulating miRNAs are correlated with tumor progression in prostate cancer PDF

Jan C. Brase, Marc Johannes, Thorsten Schlomm, Maria Fälth, Alexander Haese et al. - International Journal of Cancer, 2010
Cited by 587 OpenAlex

Serum microRNAs as non-invasive biomarkers for cancer PDF

Jan C. Brase, Daniela Wuttig, Ruprecht Kuner, Holger Sültmann - Molecular Cancer, 2010
Cited by 419 OpenAlex

Research Topics

Cancer Immunotherapy and Biomarkers (50) HER2/EGFR in Cancer Research (44) Cytokine Signaling Pathways and Interactions (32) Chemokine receptors and signaling (32) Melanoma and MAPK Pathways (32)

Affiliations

Novartis (Switzerland)
CH 2025 - 2016
Siemens (Germany)
DE 2008 - 2008
Innsbruck Medical University
AT 2012 - 2012
Universität Hamburg
DE 2012 - 2011
German Cancer Research Center
DE 2013 - 2010

External Profiles

OpenAlex Profile Search Semantic Scholar ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now